F. Raeman

692 total citations
19 papers, 258 citations indexed

About

F. Raeman is a scholar working on Rheumatology, Orthopedics and Sports Medicine and Pharmacology. According to data from OpenAlex, F. Raeman has authored 19 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 6 papers in Orthopedics and Sports Medicine and 5 papers in Pharmacology. Recurrent topics in F. Raeman's work include Bone health and osteoporosis research (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). F. Raeman is often cited by papers focused on Bone health and osteoporosis research (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). F. Raeman collaborates with scholars based in Belgium, France and Netherlands. F. Raeman's co-authors include H. Verhaegen, W. De Cock, J. De Crée, L Paolozzi, David Walker, Maxime Dougados, Pál Géher, Jacek Szechiński, Saeed Fatenejad and Joachim Sieper and has published in prestigious journals such as Annals of the Rheumatic Diseases, Osteoporosis International and Osteoarthritis and Cartilage.

In The Last Decade

F. Raeman

17 papers receiving 233 citations

Peers

F. Raeman

RHEUM

IMMUN

HEMAT

OSM

SURGE

Hee Jung Ryu South Korea

F. Maas Netherlands

Bassel Elzorkany Egypt

Miriam Teoli Italy

Samina A. Turk Netherlands

Marine Fauny France

S. Rekik Tunisia

Karen Salomon-Escoto United States

D. Ruiz Spain

Ulf Bergström Sweden

Hee Jung Ryu South Korea

F. Raeman

191 ×1.3

RHEUM

92 ×0.9

IMMUN

41 ×0.6

HEMAT

9 ×0.3

OSM

23 ×0.8

SURGE

Citations per year, relative to F. Raeman F. Raeman (= 1×) peers Hee Jung Ryu

Countries citing papers authored by F. Raeman

Since Specialization

Citations

This map shows the geographic impact of F. Raeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Raeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Raeman more than expected).

Fields of papers citing papers by F. Raeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Raeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Raeman. The network helps show where F. Raeman may publish in the future.

Co-authorship network of co-authors of F. Raeman

This figure shows the co-authorship network connecting the top 25 collaborators of F. Raeman. A scholar is included among the top collaborators of F. Raeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Raeman. F. Raeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Varkas, Gaëlle, Nathan Vastesaeger, Heleen Cypers, et al.. (2018). Association of Inflammatory Bowel Disease and Acute Anterior Uveitis, but Not Psoriasis, With Disease Duration in Patients With Axial Spondyloarthritis. Arthritis & Rheumatology. 70(10). 1588–1596. 30 indexed citations

Varkas, Gaëlle, Heleen Cypers, Philippe Carron, et al.. (2014). OP0263 First Results from “Be-Giant”: Baseline Characteristics of an Early Spondyloarthritis Cohort. Annals of the Rheumatic Diseases. 73. 161–161. 5 indexed citations

Rabenda, Véronique, Nansa Burlet, Jacques Bélaïche, et al.. (2006). Determinants of gastro-protective drugs co-prescription during treatment with nonselective NSAIDs: a prospective survey of 2197 patients recruited in primary care. Osteoarthritis and Cartilage. 14(7). 625–630. 4 indexed citations

Heijde, Désirée van der, Maxime Dougados, Pál Géher, et al.. (2006). Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis. Annals of the Rheumatic Diseases. 65(12). 1572–1577. 102 indexed citations

Luyten, Frank P., Piet Geusens, Michel Malaise, et al.. (2006). A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip. Annals of the Rheumatic Diseases. 66(1). 99–106. 31 indexed citations

Goemaere, Stefan, Dirk Vanderschueren, Jean‐Marc Kaufman, et al.. (2006). Dual Energy X-Ray Absorptiometry-Based Assessment of Male Patients Using Standardized Bone Density Values and a National Reference Database. Journal of Clinical Densitometry. 10(1). 25–33. 10 indexed citations

Rabenda, Véronique, et al.. (2005). Determinants of gastroprotective drugs co-prescription during treatment with non selective NSAIDS: A prospective survey of 2197 patients recruited in primary care. Osteoporosis International. 16.

Reginster, Jean‐Yves, K Hoszowski, Á. Balogh, et al.. (2003). Strontium ranelate : a new effective antiosteoporotic treatment reducing the incidence of vertebral and non vertebral fractures in postmenopausal women with osteoporosis. Open Repository and Bibliography (University of Liège). 2 indexed citations

Rabenda, Véronique, et al.. (2003). Use of healthcare resources related to gastrointestinal toxicity of NSAIDS. Open Repository and Bibliography (University of Liège). 1 indexed citations

10.

Meunier, Pierre J., R Lorenc, Ian Smith, et al.. (2002). Strontium ranelate: new efficient anti-osteoporotic agent for treatment of vertebral osteoporosis in postmenopausal women. Open Repository and Bibliography (University of Liège). 7 indexed citations

11.

Kaufman, Jean‐Marc, Jean-Jacques Body, Steven Boonen, et al.. (2000). L'ostéoporose involutive de la femme: stratégie thérapeutique: un point de vue actualisé du Belgian Bone Club. Ghent University Academic Bibliography (Ghent University). 1 indexed citations

12.

Kaufman, Jean‐Marc, Jean‐Jacques Body, Steven Boonen, et al.. (2000). [Involutional osteoporosis in women: therapeutic strategy. Recommendations of the Belgian Bone Club].. PubMed. 55(5). 443–8. 1 indexed citations

13.

Kaufman, Jean‐Marc, J.-P. Devogelaer, F. Raeman, et al.. (1997). Prevention and treatment of postmenopausal osteoporosis national consensus of the “belgian bone club”, November 1996. Clinical Rheumatology. 16(4). 343–345. 10 indexed citations

14.

Raeman, F., et al.. (1990). A Porcelain Gallbladder Affecting the Assessment of Bone Mineral Content. Clinical Nuclear Medicine. 15(10). 701–702. 1 indexed citations

15.

Hermans, Paul E., et al.. (1989). Multicenter comparative study of two sustained-release formulations of ibuprofen: ibuprofen diffutab tablet 600 mg and microencapsulated ibuprofen 300 mg. Current Therapeutic Research. 46(3). 411–418. 1 indexed citations

16.

Mielants, Herman, et al.. (1987). Intra-articular treatment of inflammatory arthritis: Double-blind trial comparing bufexamac with methylprednisolone acetate. Clinical Rheumatology. 6(1). 55–60. 2 indexed citations

17.

Raeman, F., et al.. (1984). An european open multicentre trial with auranofin in rheumatoid arthritis. Clinical Rheumatology. 3(S1). 33–38. 5 indexed citations

18.

Raeman, F., et al.. (1982). Enumeration of T-lymphocytes and T-lymphocyte subsets in rheumatoid arthritis using monoclonal antibodies. Clinical Rheumatology. 1(3). 194–198. 3 indexed citations

19.

Raeman, F., et al.. (1981). Enumeration of T lymphocytes subsets in autoimmune disease using monoclonal antibodies.. PubMed. 45(3). 475–9. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact